Designing new iridium(iii) arene complexes of naphthoquinone derivatives as anticancer agents: a structure–activity relationship study

Leila Tabrizi and Hossein Chiniforoshan

Dalton Trans., 2017, 46, 2339
DOI: 10.1039/C6DT04339A

Switching between upconversion luminescence imaging and therapy in vitro enabled by NIR excitation modulation of nanocomposites

Yuan Jiang, Yale Hong, Yuan-Yuan Liu, Yue Guan, Junxun Zhou, Haifang Wang and Lining Sun

J. Mater. Chem. C, 2024, 12, 11938
DOI: 10.1039/D4TC01535E

Fluorination on non-photolabile dppz ligands for improving Ru(ii) complex-based photoactivated chemotherapy

Rena Boerhan, Weize Sun, Na Tian, Youchao Wang, Jian Lu, Chao Li, Xuexin Cheng, Xuesong Wang and Qianxiong Zhou

Dalton Trans., 2019, 48, 12177
DOI: 10.1039/C9DT01594A

The development of anticancer ruthenium(ii) complexes: from single molecule compounds to nanomaterials

Leli Zeng, Pranav Gupta, Yanglu Chen, Enju Wang, Liangnian Ji, Hui Chao and Zhe-Sheng Chen

Chem. Soc. Rev., 2017, 46, 5771
DOI: 10.1039/C7CS00195A

Harnessing ruthenium(II) as photodynamic agents: Encouraging advances in cancer therapy

Jiangping Liu, Chen Zhang, Thomas W. Rees, Libing Ke, Liangnian Ji and Hui Chao

Coordination Chemistry Reviews, 2018, 363, 17
DOI: 10.1016/j.ccr.2018.03.002

Role of Electrostatics in Influencing the Pathway by Which the Excited State of [Ru(bpy)3]2+ Is Deactivated by Ferrocene Derivatives

Nicolas Pascual-Leone, Eric Conklin, Gabriel A. Andrade, Joel Rosenthal and Elizabeth R. Young

J. Phys. Chem. A, 2019, 123, 7673
DOI: 10.1021/acs.jpca.9b04427

Synthesis and In Vitro Studies of Photoactivatable Semisquaraine-type Pt(II) Complexes

Kevin Morales, Sergi Rodríguez-Calado, Jordi Hernando, Julia Lorenzo, Antonio Rodríguez-Diéguez, Carlos Jaime, Pau Nolis, Mercè Capdevila, Òscar Palacios, Marta Figueredo and Pau Bayón

Inorg. Chem., 2022, 61, 7729
DOI: 10.1021/acs.inorgchem.1c03957

The Development of Ru(II)-Based Photoactivated Chemotherapy Agents

Yongjie Chen, Lijuan Bai, Pu Zhang, Hua Zhao and Qianxiong Zhou

Molecules, 2021, 26, 5679
DOI: 10.3390/molecules26185679

Type I photodynamic therapy by organic–inorganic hybrid materials: From strategies to applications

Yu-Ying Wang, Yan-Cen Liu, Hongwei Sun and Dong-Sheng Guo

Coordination Chemistry Reviews, 2019, 395, 46
DOI: 10.1016/j.ccr.2019.05.016

Self-assembled ruthenium (II) metallacycles and metallacages with imidazole-based ligands and their in vitro anticancer activity

Yibo Zhao, Liqian Zhang, Xu Li, Yanhui Shi, Ruru Ding, Mengting Teng, Peng Zhang, Changsheng Cao and Peter J. Stang

Proc. Natl. Acad. Sci. U.S.A., 2019, 116, 4090
DOI: 10.1073/pnas.1818677116

The medicinal chemistry of ferrocene and its derivatives

Malay Patra and Gilles Gasser

Nat Rev Chem, 2017, 1
DOI: 10.1038/s41570-017-0066

Ruthenium coordination compounds of biological and biomedical significance. DNA binding agents

Viktor Brabec and Jana Kasparkova

Coordination Chemistry Reviews, 2018, 376, 75
DOI: 10.1016/j.ccr.2018.07.012

Azinyl derivatives of ferrocene and cymantrene. Synthesis and properties

I. A. Utepova, A. A. Musikhina and O. N. Chupakhin

Russ Chem Bull, 2016, 65, 2523
DOI: 10.1007/s11172-016-1618-2

Discovery of organometallic Ruthenium(II)-arene complexes of lidocaine as improved photocytotoxic agents

Leila Tabrizi and Hossein Chiniforoshan

Polyhedron, 2016, 119, 575
DOI: 10.1016/j.poly.2016.09.031

Study on antitumor activity of three ruthenium arene complexes in vitro

Xiaolong Peng, Qiang Tang, Huiyun Zhu, Lijuan Bai, Hua Zhao and Yongjie Chen

Journal of Inorganic Biochemistry, 2023, 247, 112310
DOI: 10.1016/j.jinorgbio.2023.112310

Type I Photosensitizers Revitalizing Photodynamic Oncotherapy

Dapeng Chen, Qian Xu, Wenjun Wang, Jinjun Shao, Wei Huang and Xiaochen Dong

Small, 2021, 17
DOI: 10.1002/smll.202006742